MTOR and pancreatic neoplasm: Overall, these data allow us to speculate that both apoptosis induction and mTOR inhibition, resulting after combined therapy, might contribute to the synergistic reduction of cell viability observed in pancreatic cancer cells, and also that the cytotoxic effect is due to the increase in oxidative stress.